The Breakfast Briefing: 4.7.2014

Everything you need to know to start your day.

Victims’ families demand prosecution of GM employees
Some family members of people who died as a result of defective ignition switches in Chevrolet Cobalts are calling for General Motors employees to face prosecution over its decision not to recall the cars for more than a decade. Yet legal experts say it is considerably harder to prove wrongdoing by individuals rather than a company. Meanwhile, GM executives met with newly retained superlawyer Kenneth Feinberg last week to discuss the complicated question of how to compensate victims.

Could Yahoo be up for an Emmy?
Yahoo is following the lead of Netflix and Amazon by planning four half-hour-long comedy series from established writers and directors that could make the company a player in original content. The move would enable Yahoo to take on cable networks and streaming services for coveted advertising dollars.

Winter comes at the worst time for HBO Go app
Thousands of users saw an error message or long load times during the season four premiere of smash fantasy series Game of Thrones on HBO’s Go mobile app. The network tweeted some humorous, show-themed messages in response.

White House voices displeasure with ‘surprise’ selfie
The White House counsel’s office has had "conversations" with Samsung over the selfie Boston Red Sox slugger David Ortiz took with President Barack Obama last week, senior aide Dan Pfeiffer said Sunday on Face the Nation. Pfeiffer didn’t elaborate on the calls, but joked that it "may be the end of all selfies" at the White House.

No weekend off for pharma M&A
Sun Pharmaceuticals Industries has agreed to take over fellow Indian drug-maker Ranbaxy Laboratories in a deal valued at $3.2 billion. The Food and Drug Administration has banned imports from four of Ranbaxy’s five Indian factories. Elsewhere, Roche said it has acquired IQuum, a Massachusetts-headquartered maker of molecular diagnostics platforms.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in